Prognosis
AstraZeneca to Test Combining Its Covid-19 Vaccine With Russia’s
- Company to test combination of AZD1222 and Sputnik V shot
- Combination may lead to stronger immune response, company says
This article is for subscribers only.
AstraZeneca Plc plans to start a clinical trial combining its Covid-19 vaccine with Russia’s Sputnik V in an effort to determine whether the two inoculations work better together than individually.
This “may be an important step in generating wider protection through a stronger immune response and better accessibility,” the company said in a website statement. Volunteers aged 18 and older will be enrolled in the trial that will assess safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca and Oxford University and Sputnik V, developed by Russia’s Gamaleya Institute, according to the statement.